These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28429199)

  • 61. Cardiovascular benefits of bariatric surgery in morbidly obese patients.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Obes Rev; 2011 Jul; 12(7):515-24. PubMed ID: 21348922
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet.
    Srivastava A; Stevenson M; Lee J; Hall C; Palaia T; Zhao CL; Lau R; Brathwaite C; Ragolia L
    Obes Surg; 2022 Jun; 32(6):2010-2022. PubMed ID: 35419698
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in Non-Diabetic Comorbid Disease Status Following Laparoscopic Vertical Sleeve Gastrectomy (LVSG) Versus Laparoscopic Roux-En-Y Gastric Bypass (LRYGB) Procedures: a Systematic Review of Randomized Controlled Trials.
    Osland E; Yunus RM; Khan S; Memon B; Memon MA
    Obes Surg; 2017 May; 27(5):1208-1221. PubMed ID: 27896647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.
    Bower G; Toma T; Harling L; Jiao LR; Efthimiou E; Darzi A; Athanasiou T; Ashrafian H
    Obes Surg; 2015 Dec; 25(12):2280-9. PubMed ID: 25917981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease.
    Dixon JB
    Clin Liver Dis; 2014 Feb; 18(1):129-46. PubMed ID: 24274869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.
    Cazzo E; Pareja JC; Chaim EA
    Sao Paulo Med J; 2017; 135(3):277-295. PubMed ID: 28562737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.
    Pinheiro JS; Schiavon CA; Pereira PB; Correa JL; Noujaim P; Cohen R
    Surg Obes Relat Dis; 2008; 4(4):521-5; discussion 526-7. PubMed ID: 18539540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gastric Bypass in Older Patients: Complications, Weight Loss, and Resolution of Comorbidities at 2 Years in a Matched Controlled Study.
    Montastier E; Becouarn G; Bérard E; Guyonnet S; Topart P; Ritz P
    Obes Surg; 2016 Aug; 26(8):1806-13. PubMed ID: 26738894
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.
    Jimenez LS; Mendonça Chaim FH; Mendonça Chaim FD; Utrini MP; Gestic MA; Chaim EA; Cazzo E
    Obes Surg; 2018 Oct; 28(10):3131-3135. PubMed ID: 29725976
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nonalcoholic fatty liver disease in individuals with severe obesity.
    Haynes P; Liangpunsakul S; Chalasani N
    Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis.
    Li J; Lai D; Wu D
    Obes Surg; 2016 Feb; 26(2):429-42. PubMed ID: 26661105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.
    Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C
    Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Tzovaras G
    Clin Obes; 2018 Jun; 8(3):159-169. PubMed ID: 29573175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
    Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; Earnest A; O'Brien PE; Brown WA
    Obes Surg; 2017 Jun; 27(6):1533-1542. PubMed ID: 27966066
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improvement in quality of life after bariatric surgery: sleeve versus bypass.
    Versteegden DPA; Van Himbeeck MJJ; Nienhuijs SW
    Surg Obes Relat Dis; 2018 Feb; 14(2):170-174. PubMed ID: 29150392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.